IL22 and psoriasis: A mixture of five inflammatory molecules (TNF-α, IL-1α, IL-17A, IL-22, and oncostatin M; 10 ng/mL each) was used to stimulate HaCaT cells to mimic the microenvironment of psoriasis, as described previously [32].